nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—gall bladder—bile duct cancer	0.425	0.425	CbGeAlD
Lorazepam—UGT2B15—pancreas—bile duct cancer	0.196	0.196	CbGeAlD
Lorazepam—UGT2B15—liver—bile duct cancer	0.125	0.125	CbGeAlD
Lorazepam—TSPO—pancreas—bile duct cancer	0.0702	0.0702	CbGeAlD
Lorazepam—GABRB3—pancreas—bile duct cancer	0.0638	0.0638	CbGeAlD
Lorazepam—TSPO—liver—bile duct cancer	0.0447	0.0447	CbGeAlD
Lorazepam—GABRB3—liver—bile duct cancer	0.0406	0.0406	CbGeAlD
Lorazepam—TSPO—lymph node—bile duct cancer	0.0343	0.0343	CbGeAlD
